ASAN FOUNDATION
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1989-06-23
- Employees
- 501
- Market Cap
- -
- Website
- https://ails.amc.seoul.kr
Rivaroxaban Versus Warfarin in Acute Ischemic Stroke With Atrial Fibrillation
Phase 2
Completed
- Conditions
- Ischemic StrokeTransient Ischemic Attack
- Interventions
- First Posted Date
- 2014-01-23
- Last Posted Date
- 2017-02-08
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 195
- Registration Number
- NCT02042534
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Serum Cholesterol and Gastric Neoplasm
- Conditions
- Gastric Cancer
- Interventions
- Other: No intervention
- First Posted Date
- 2014-01-22
- Last Posted Date
- 2016-12-06
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 1178
- Registration Number
- NCT02041312
- Locations
- 🇰🇷
Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea, Republic of
Efficacy of Bronchial Thermoplasty in Korean
Phase 4
- Conditions
- Asthma
- Interventions
- Procedure: bronchial thermoplasty system
- First Posted Date
- 2014-01-09
- Last Posted Date
- 2014-08-19
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 9
- Registration Number
- NCT02031263
- Locations
- 🇰🇷
Department of Pulmonary and Critical Care Medicine and Clinical Research Center for Chronic Obstructive Airway Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
The Treatment of Posterior Semicircular Canal Benign Paroxysmal Positional Vertigo
Phase 3
Completed
- Conditions
- Benign Paroxysmal Positional Vertigo
- Interventions
- Procedure: Modified Epley maneuverProcedure: Semont maneuverProcedure: Reverse Epley maneuver
- First Posted Date
- 2014-01-08
- Last Posted Date
- 2014-01-08
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 99
- Registration Number
- NCT02029508
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Songpa-gu, Korea, Republic of
Assessment of CMV-specific ELISPOT Assay for Predicting CMV Infection in Kidney Transplant Recipients
Completed
- Conditions
- Kidney Transplantation Recipients
- First Posted Date
- 2014-01-01
- Last Posted Date
- 2015-09-25
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 199
- Registration Number
- NCT02025335
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Strategy to Improve Adherence of Roflumilast
Phase 4
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- First Posted Date
- 2013-12-23
- Last Posted Date
- 2013-12-23
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 80
- Registration Number
- NCT02018432
- Locations
- 🇰🇷
Department of Pulmonary and Critical Care Medicine and Clinical Research Center for Chronic Obstructive Airway Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Children and Adolescents
Phase 1
- Conditions
- Non-malignant DiseaseHaploidentical Hematopoietic Stem Cell TransplantationMalignant Disease
- Interventions
- Biological: anti-thymocyte globulinBiological: filgrastimRadiation: Total body irradiationProcedure: TCRαβ-depleted hematopoietic cell transplantationDevice: CliniMACS
- First Posted Date
- 2013-12-18
- Last Posted Date
- 2017-03-28
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT02014506
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Neoadjuvant Chemotherapy of 6 Cycles vs 8 Cycles in Node Positve Breast Cancer
Phase 3
Completed
- Conditions
- Breast Cancer
- Interventions
- Drug: FEC3-D3
- First Posted Date
- 2013-12-05
- Last Posted Date
- 2017-08-29
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 250
- Registration Number
- NCT02001506
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Additional 4 Cycles of Cisplatin (CDDP4) in Patients With Triple Negative Breast Cancer for Neoadjuvant Chemotherapy
Phase 2
Completed
- Conditions
- Breast Cancer
- Interventions
- Drug: AC4-CDDP4
- First Posted Date
- 2013-12-05
- Last Posted Date
- 2014-12-02
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 88
- Registration Number
- NCT02001519
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Diagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer
Phase 3
Completed
- Conditions
- Recurrent Breast CancerStage IV Breast Cancer
- Interventions
- Drug: [18F]fluoroestradiol (FES)
- First Posted Date
- 2013-11-18
- Last Posted Date
- 2016-12-08
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 93
- Registration Number
- NCT01986569
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath